Literature DB >> 20703866

Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe.

Riki Okita1, Katsuhiko Shimizu, Takeshi Mimura, Yoshihiro Miyata, Morihito Okada, Koji Arihiro.   

Abstract

We report a case of suggestive synchronous triple squamous cell carcinoma (Sq) of the lung that occurred in the same lobe. Under a clinical diagnosis of triple lung cancer, lobectomy was performed. Pathological examination revealed two well-differentiated Sq and one poorly differentiated Sq. The analysis of epidermal growth factor receptor-tyrosine kinase mutations showed no mutation in each tumor. However, pathological findings and the positive rate of immunochemical reaction of p53 and Ki-67 were different in each tumor.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20703866     DOI： 10.1007/s11748-009-0476-3

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  9 in total

1.  Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.

Authors:  Yih-Leong Chang; Chen-Tu Wu; Shu-Chen Lin; Chin-Fu Hsiao; Yuh-Shan Jou; Yung-Chie Lee
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

2.  Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.

Authors:  Ayesha S Bryant; Sara J Pereira; Daniel L Miller; Robert James Cerfolio
Journal:  Ann Thorac Surg       Date:  2006-11       Impact factor: 4.330

3.  Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.

Authors:  Hiroyoshi Tsubochi; Nobuyuki Sato; Misae Hiyama; Mitsuomi Kaimori; Shunsuke Endo; Yasunori Sohara; Tadashi Imai
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

4.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

5.  p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma.

Authors:  Marcel Th M van Rens; Erik J E Eijken; Johannes R J Elbers; Jan-W J Lammers; Marcel G J Tilanus; Pieter J Slootweg
Journal:  Cancer       Date:  2002-01-01       Impact factor: 6.860

6.  Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis.

Authors:  M T van Rens; P Zanen; A Brutel de La Rivière; H R Elbers; H A van Swieten; J M van Den Bosch
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

7.  Surgical treatment of multiple primary lung cancers.

Authors:  A F Verhagen; H J van de Wal; A L Cox; L K Lacquet
Journal:  Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 1.827

8.  Diagnosis and management of synchronous lung cancers.

Authors:  M K Ferguson; T R DeMeester; J DesLauriers; A G Little; M Piraux; H Golomb
Journal:  J Thorac Cardiovasc Surg       Date:  1985-03       Impact factor: 5.209

9.  Multiple primary lung carcinomas: prognosis and treatment.

Authors:  T K Rosengart; N Martini; P Ghosn; M Burt
Journal:  Ann Thorac Surg       Date:  1991-10       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.